This inventor holds 1 USPTO granted patent. Top assignee: Methylgene, Inc.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Zuomei Li: Innovator in Gene Expression Modulation
Introduction
Zuomei Li is a prominent inventor based in Kirkland, CA. He has made significant contributions to the field of gene expression modulation. His innovative work focuses on the development of therapies that utilize antisense oligonucleotides to inhibit gene expression.
Latest Patents
Zuomei Li holds a patent titled "Modulation of gene expression by combination therapy." This invention relates to the modulation of gene expression, particularly through compositions that include antisense oligonucleotides. These compositions are designed to inhibit the expression of a gene in operable association with protein effectors of that gene's product. Additionally, the invention addresses the modulation of mammalian gene expression regulated by methylation. He has 1 patent to his name.
Career Highlights
Zuomei Li is associated with Methylgene, Inc., where he continues to advance research in gene therapy. His work has the potential to impact various medical fields, particularly in the treatment of genetic disorders.
Collaborations
Some of his notable coworkers include Jeffrey M Besterman and Robert A Macleod. Their collaborative efforts contribute to the innovative research environment at Methylgene, Inc.
Conclusion
Zuomei Li's contributions to gene expression modulation highlight his role as a key innovator in biotechnology. His work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile